“… 4,8 Although a supportive role of neoadjuvant/adjuvant chemotherapy is not confirmed in all primary hepatic sarcomas, experience in the pediatric population with adjuvant chemotherapy after complete resection of UES has demonstrated improved survival compared with patients who undergo surgical resection alone in this chemosensitive subtype. 3,20,21 More recently, aggressive multimodal therapy including neoadjuvant therapy and liver transplantation have been supported as a surgical option for patients whose tumors are initially unresectable or recur. 4 …”